← FDA DRUG APPROVALS

FDA ANDA · ANDA071700

METHYLDOPA

Sponsor: CHARTWELL RX

APPLICATION
ANDA071700
TYPE
ANDA
ORIGINAL APPROVAL
1988-03-02
LATEST ACTION
1996-06-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METHYLDOPADiscontinued
METHYLDOPA 125MG · TABLET · ORAL

Approval history

1996-06-05Labeling · Supplement 4AP
1995-03-27Manufacturing (CMC) · Supplement 3AP
1993-02-12Labeling · Supplement 2AP
1991-02-22Labeling · Supplement 1AP
1988-03-02OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →